Dr. Tetyana's Perspective
on Vaccination and Natural Immunity
Up until now we were told that vaccine hesitancy is restricted to developed countries, where vaccines have become 'victims of their own success.' With the WHO announcing vaccine hesitancy to be one of the top global health threats, comes their confession that vaccine hesitancy is global. Why is that? Why are vaccines not well received even in countries where disease mortality is still high? Aren’t vaccines saving lives there for everyone to see? Perhaps, only in theory.
In reality, non-live vaccines that contain aluminum adjuvants are increasing rather than reducing childhood mortality in developing countries. And those deaths come from non-specific infections. Check out these studies on the effects of aluminum adjuvant-containing DTP and pentavalent vaccines on infant survival:
Fisker et al. (2014): “Studies from low-income countries indicate that co-administration of inactivated diphtheria-tetanus-pertussis (DTP) vaccine and live attenuated measles vaccine (MV) is associated with increased mortality compared with receiving MV only. Pentavalent (DTP - H. influenzae type B - Hepatitis B) vaccine is replacing DTP in many low-income countries, and yellow fever vaccine (YF) has been introduced to be given together with MV. Pentavalent and YF vaccines were introduced in Guinea-Bissau in 2008. We investigated whether co-administration of pentavalent vaccine with MV and yellow fever vaccine has similar negative effects. RESULTS: During 6 months of follow-up, the adjusted mortality rate ratio (MRR) for co-administered live and inactivated vaccines compared with live vaccines only was 3.24 (1.20-8.73). For MV+YF+pentavalent compared with MV+YF only, the adjusted MRR was 7.73 (1.79-33.4). CONCLUSION: In line with previous studies of DTP, the present results indicate that pentavalent vaccine co-administered with MV and YF is associated with increased mortality.”
Mogensen et al. (2017): “Among 3-5-month-old children, having received DTP (±OPV) was associated with a mortality hazard ratio (HR) of 5.00 (95% CI 1.53-16.3) compared with not-yet-DTP-vaccinated children. Differences in background factors did not explain the effect. The negative effect was particularly strong for children who had received DTP-only and no OPV (HR=10.0 (2.61-38.6)). All-cause infant mortality after 3 months of age increased after the introduction of these vaccines (HR=2.12 (1.07-4.19)). CONCLUSION: DTP was associated with increased mortality.”
There are two major directions the immune response can take: Th1 and Th2. The Th1 response is necessary to fight infections. But aluminum adjuvants take the immune system into the Th2 direction and away from Th1, derailing the ability of the immune system to fight infections. Communities in developing countries may see an uptick of deaths from infections soon after babies are vaccinated. Why wouldn't that make them vaccine-hesitant?
The majority of vaccines used in developed countries also contain aluminum adjuvants. Did you notice your baby getting sick after each round of vaccines, necessitating rounds of antibiotics? Would you be surprised by now to know that a pilot study done in the U.S. found that fully vaccinated children were 3.8-times more likely to have had ear infections and 5.9-times more likely to have had pneumonia compared to completely unvaccinated children?
Keeping aluminum adjuvants out is good for the immune system. But there is much more you can do to keep the immune system in top shape. Natural Immunity Fundamentals (NIF class) goes over the whole spectrum of factors that either strengthen or weaken the immune system. Sign up today to take the class.